ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2625 • ACR Convergence 2025

    Early Detection of Knee Osteoarthritis – The Role of a Composite Disease Activity Metric: Data from the Osteoarthritis Initiative

    Julieann Patarini1, Timothy McAlington2, Jonggyu Baek1, Emily Kirillov3, Nhung Vo3, Michael Richard3, Ming Zhang4, Matthew Harkey5, Grace Lo6, Shao-Hsien Liu1, Kate Lapane1, Charles Eaton7, James Mackay8 and Jeffrey Driban9, 1UMass Chan Medical School, Worcester, MA, 2UMass Chan School of Medicine, Arlington, MA, 3Tufts Medical Center, Boston, MA, 4Boston University, Westford, MA, 5Michigan State University, East Lansing, MI, 6Baylor College of Medicine / MEDVAMC, Houston, TX, 7Brown University, Pawtucket, RI, 8University of Cambridge; Norwich Medical School, San Diego, CA, 9University of Massachusetts Chan Medical School, Marlborough, NH

    Background/Purpose: Bone marrow lesions (BMLs) and effusion-synovitis are frequent and dynamic disease processes detected from early- to late-stage knee OA. These processes are associated with…
  • Abstract Number: 2098 • ACR Convergence 2025

    Responder Phenotype Analysis for Intra-Articular Injections: Secondary Analysis from a Large Multi-Site Crossover Clinical Trial

    Natalie Keller1, Bryant England2, Katherine Wysham3, Mercedes Quinones4, Marianna Olave5, Sarah Wetzel6, Hannah Brubeck7, Rachel Gillcrist6, Criswell Lavery8, Bibiana Ateh9, Bridget Kramer2, Kimberly Hayes6, Rui Xiao8, Kaitian Jin8, Alexis Ogdie8, Daniel K. White10, Tuhina Neogi11, Carla Scanzello12 and Joshua Baker8, 1University of Oklahoma, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4Howard University Hospital and Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, 5Brown University, Philadelphia, PA, 6Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 7VA Puget Sound Health Care System, Seattle, WA, 8University of Pennsylvania, Philadelphia, PA, 9Washington VA Medical Center, Washington, District of Columbia, 10University of Delaware, Newark, DE, 11Boston University School of Medicine, Boston, MA, 12University of Pennsylvania, Philadelphia

    Background/Purpose: Intra-articular (IA) corticosteroid injections are commonly utilized for pain management in knee osteoarthritis (KOA). However, clinical characteristics associated with a greater benefit from corticosteroid…
  • Abstract Number: 2082 • ACR Convergence 2025

    Pharmacokinetic Profile of MM-II Following a Single Intra-Articular Injection in Patients with Knee Osteoarthritis in a Phase 2b Randomized, Controlled, Dose-Ranging Trial

    Thomas Schnitzer1, Xavier Chevalier2, Helene Rovsing3, Edith Lau4, Sidsel Boll5, Ballari Brahmachari6, Richard Chou7, Tarini Joshi8, Roni Wechsler9, Sveta Weiner10, Mudgal Kothekar11, Asger Bihlet12 and Philip Conaghan13, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Henri Mondor Hospital, University Paris XII UPEC, Créteil, France, 3Sanos Clinic, Gandrup, Denmark, 4Hong Kong Center for Clinical Research, Hong Kong, Hong Kong, 5Sanos Clinic, Vejle, Denmark, 6Sun Pharmaceuticals Industries Ltd., mumbai, Maharashtra, India, 7Sun Pharmaceutical Industries, Inc., Princeton, NJ, 8Sun Pharmaceutical Industries Limited, Mumbai, India, 9Moebius Medical, Tel Aviv, Israel, 10Sun Pharma Advanced Research Company Limited, Princeton, NJ, 11Sun Pharma Advanced Research Company Limited, Andheri (E), Princeton, NJ, 12NBCD A/S, Herlev, Denmark, 13University of Leeds, Leeds, United Kingdom

    Background/Purpose: MM-II is a first-in-class investigational treatment for knee OA pain that consists of a one-time IA injection of empty liposomes comprised of phospholipids dipalmitoylphosphatidylcholine…
  • Abstract Number: 1800 • ACR Convergence 2025

    The Role of Nociceptor-Expressed Piezo2 in Nervous System Immune Cell Infiltration in a Mouse Model of Osteoarthritis

    Natalie Adamczyk1, Terese Geraghty2, Shingo Ishihara3, alia obeidat2, Jun Li2, Anne-Marie Malfait2 and Rachel Miller1, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, 3Rush University, Chicago

    Background/Purpose: Osteoarthritis is one of the leading causes of chronic pain and disability worldwide with 500 million people affected. We have previously reported that nociceptor-conditional…
  • Abstract Number: 1780 • ACR Convergence 2025

    Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts

    Abdelhak Belmadani1, Dongjun Ren1, Daniel Hoffman2, Nirupa Jayraj1, Paola Pacifico1, Vince Truong3, Patrick Walsh3, Daniela Menichella1, Anna Rapp4, Carla Scanzello5, Rachel Miller6, Richard Miller7 and Anne-Marie Malfait8, 1Northwestern University Chicago, Chicago, IL, 2Rush University, Chicago, IL, 3Anatomic Inc, Minneapolis, MN, 4University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, 6Rush University Medical Center, Chicago, IL, 7Northwestern University, Chicago, 8Rush University Medical Center, Chicago

    Background/Purpose: Joint pain is one of the most significant clinical hallmarks of knee osteoarthritis (OA). Knee OA is a chronic degenerative disease of the joints…
  • Abstract Number: 0788 • ACR Convergence 2025

    Spatiotemporal Gait Differences Between Fallers and Non-Fallers in People with Knee Osteoarthritis

    Joy Itodo, Steven Garcia, Oiza Peters, Ogundoyin Ogundiran and Kharma Foucher, UNIVERSITY OF ILLINOIS, CHICAGO, Chicago, IL

    Background/Purpose: People with knee osteoarthritis (OA) have higher fall rates than their age-matched peers. Studies in another at-risk group, healthy older adults, have linked fall…
  • Abstract Number: 0328 • ACR Convergence 2025

    High synovial fluid leukocyte counts and markers of TLR activation correlate with poorer response to injections in patients with knee OA

    Lance Murphy1, Baofeng Hu2, Vu Nguyen3, Bryant England4, Katherine Wysham5, Mercedes Quinones6, Joshua Baker3 and Carla Scanzello3, 1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2University of Pennsylvania, Wynnewood, PA, 3University of Pennsylvania, Philadelphia, PA, 4University of Nebraska Medical Center, Omaha, NE, 5VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 6Washington DC VA Medical Center, Bethesda, MD

    Background/Purpose: Toll-like receptors (TLRs) are pattern-recognition receptors of the innate immune response and are important in driving the initial activation of myeloid lineage cells to…
  • Abstract Number: 0313 • ACR Convergence 2025

    People with Knee Osteoarthritis Infrequently Seek Medical Care for Arthritis, Even Those With Severe Disease

    Grace Lo1, Shunshun Yan2, Julieann Patarini3, Timothy McAlington4, Charles Eaton5 and Jeffrey Driban6, 1Baylor College of Medicine / MEDVAMC, Houston, TX, 2Baylor College of Medicine, Houston, 3UMass Chan Medical School, Worcester, MA, 4UMass Chan School of Medicine, Arlington, MA, 5Brown University, Providence, RI, 6University of Massachusetts Chan Medical School, Marlborough, NH

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, a condition associated with substantial disability. Providers are often uncomfortable managing arthritis, and patients with…
  • Abstract Number: 2624 • ACR Convergence 2025

    Results of Large Multi-Site Pragmatic Clinical Trial Comparing Corticosteroids or Blinded Lidocaine-only Injections in Treating Osteoarthritis of the Knee

    Joshua Baker1, Katherine Wysham2, Mercedes Quinones3, Bryant England4, Kaitian Jin1, Marianna Olave5, Sarah Wetzel6, Rachel Gillcrist7, Criswell Lavery1, Natalie Keller8, Kimberly Hayes9, Bridget Kramer4, Hannah Brubeck10, Bibiana Ateh11, Daniel K. White12, Alexis Ogdie13, Rui Xiao1, Tuhina Neogi14 and Carla Scanzello1, 1University of Pennsylvania, Philadelphia, PA, 2VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 3Washington DC VA Medical Center, Bethesda, MD, 4University of Nebraska Medical Center, Omaha, NE, 5Brown University, Philadelphia, PA, 6Drexel University, Pittsburgh, PA, 7Dartmouth College, Lebanon, NH, 8University of Oklahoma, Philadelphia, PA, 9Teachers College, Columbia University, Philadelphia, PA, 10VA Puget Sound Health Care System, Seattle, WA, 11Washington VA Medical Center, Washington, District of Columbia, 12University of Delaware, Newark, DE, 13Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Wilmington, DE, 14Boston University School of Medicine, Boston, MA

    Background/Purpose: Intra-articular corticosteroids are widely used for routine management of chronic pain from knee osteoarthritis (KOA), though estimates of their benefit vary widely. We aimed…
  • Abstract Number: 2097 • ACR Convergence 2025

    Trajectories of psychological symptoms during an 18-month Diet + Exercise intervention in overweight or obese adults with osteoarthritis

    Lily Alomari1, Daniel Beavers2, Kate Queen3, Shannon Mihalko4, Gary Miller4, Elena Losina5, Paul DeVita6, david Hunter7, Jovita Newman4, Sara Quandt8, Mary Lyles8, Sandra Soto3, Joanne Jordan9, Leigh Callahan3, Stephen Messier10 and Becki Cleveland11, 1Kansas City University, Raleigh, 2Wake forest university, Winston Salem, 3UNC, Chapel Hill, 4WFU, Winston Salem, 5BWH, Boston, MA, 6East Carolina University, Greenville, 7Sydney Musculoskeletal Health, University of Sydney, St Leonards, New South Wales, Australia, 8WFU, Winston-Salem, 9University of North Carolina at Chapel Hill, Chapel Hill, NC, 10WFU, Winston-Salem, NC, 11University of North Carolina, Chapel Hill, NC

    Background/Purpose: Psychological symptoms (PsySx) have been associated with osteoarthritis (OA), and exercise may improve PsySx. We aimed to identify unique trajectories of PsySx over the…
  • Abstract Number: 2081 • ACR Convergence 2025

    Radiologic surveillance in the Phase II RCT of LEVI-04, a novel neurotrophin-3 inhibitor, in people with knee osteoarthritis: exclusions at screening

    Ali Guermazi1, Philip Conaghan2, C Michael Perkins3, Claire Herholdt4, Iwona Bombelka5 and Simon Westbrook6, 1Boston University, West Roxbury, MA, 2University of Leeds, Leeds, United Kingdom, 3Levicept, Sandwich, United Kingdom, 4Levicept Ltd, Ashtead, United Kingdom, 5Levicept, Sandwich, Kent, United Kingdom, 6Levicept Ltd, Sandwich, United Kingdom

    Background/Purpose: LEVI-04 is a first-in-class fusion protein (p75NTR-Fc) that supplements the endogenous p75NTR binding protein, providing analgesia via inhibition of NT-3 activity. Like p75NTR, LEVI-04…
  • Abstract Number: 1801 • ACR Convergence 2025

    Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype

    Richard Loeser1, Jorge Fernandez Davila1, Philip Coryell2, Susan Chubinskaya3 and Doug Phanstiel4, 1University of North Carolina, Chapel Hill, NC, 2University of North Carolina-Chapel Hill, Chapel Hill, NC, 3University of Texas Medical Branch, Galveston, TX, 4University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Protease cleavage of matrix proteins generates matrix fragments including fibronectin fragments (FN-f) found in OA cartilage and synovial fluid. Matrix fragments or “matrikines” activate…
  • Abstract Number: 1738 • ACR Convergence 2025

    Coexpression and Infiltration of Endoplasmic Reticulum Stress Proteins Together With CD34+ Fibroblast-like Synoviocytes In Human Inflamed Synovial Membranes

    Zoe Gendebien1, Pauline Salpetier2, Celine Deroyer2, Genevieve Paulissen2, Alexandre Hego2, Gaetan Lefevre2, Christophe Poulet2, Sophie Neuville2, Patrick Durez3, Patrice Hemon4, Nadege Marec5, Elettra Bianchi2, Philippe Delvenne2, Clio ribbens2 and Dominique de Seny2, 1ULiege, Liège, Belgium, 2ULiege, Liege, Belgium, 3Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatologie, Brussels, Brussels Hoofdstedelijk Gewest, Belgium, 4Brest, Brest, Belgium, 5Brest, Brest, France

    Background/Purpose: A strong crosstalk exists between endoplasmic reticulum (ER) stress and synovitis. Several ER chaperone proteins, besides their function in protein folding, can play a…
  • Abstract Number: 0787 • ACR Convergence 2025

    The Cost-effectiveness of Physical Therapy for Patients with Meniscal Tear and Osteoarthritis

    Samantha Chin1, Sasha Aronson1, Jamie Collins1, Faith Selzer1, Ying Heidi Yang1, Leslie Bisson2, Antonia Chen3, Morgan Jones4, Clare Norton1, Karen Smith1, Kurt Spindler5, Jeffrey Katz6 and Elena Losina7, 1Brigham and Women's Hospital, Boston, MA, 2University of Buffalo, Buffalo, 3Brigham and Women's Hospital, Newton, MA, 4Mass General Brigham, Boston, 5Cleveland Clinic, Cleveland, 6Brigham and Women's Hospital, Brookline, MA, 7BWH, Boston, MA

    Background/Purpose: Based on several RCTs comparing outcomes of arthroscopic partial meniscectomy (APM) to non-operative management in persons with meniscal tears and OA, physical therapy (PT)…
  • Abstract Number: 0329 • ACR Convergence 2025

    Machine Learning-Based Model to Predict Rapid Structural Progression in Knee Osteoarthritis

    Maria Fernanda Gonzalez Hernandez1, Ignacio rego Pérez2, Isabel Rodríguez Valle3, Jorge Vázquez García4, Vanesa Balboa5, Sara Relaño Fernández4, María C. de Andrés6, Lucía Lourido7, Valentina Calamia7, Rocio Paz González4, Patricia Quaranta7, Patricia Fernández-Puente4, Nicola Veronese8, Cristina Ruiz-Romero9, Natividad Oreiro10 and francisco J Blanco11, 1Instituto de Investigacion Biomedica de A Coruna (INIBIC), A coruña, Galicia, Spain, 2Department of Rheumatology, Rheumatology Research Group (GIR) Biomedical Re-search Institute (INIBIC), A Coruña, Spain, 3Instituto de Investigacion Biomedica de A Coruna (INIBIC), Coruña, Galicia, Spain, 4Instituto de Investigacion Biomedica de A Coruna (INIBIC), coruña, Spain, 5Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, coruña, Spain, 6Instituto de Investigación Biomédica de A Coruña (INIBIC), Grupo de Investigación de Reumatología (GIR), A Coruña, Spain, 7Instituto de Investigacion Biomedica de A Coruna (INIBIC), coruna, Spain, 8Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, palermo, Italy, 9Department of Rheumatology, Rheumatology Research Group (GIR) Biomedical Re-search Institute (INIBIC),, A Coruña, Spain, 10CHUAC, La Coruna, Spain, 11INIBIC-University of A Coruña, A Coruña, Galicia, Spain

    Background/Purpose: Osteoarthritis (OA) is the most common chronic joint disorder, characterized by structural cartilage and bone damage that often causes pain and disability. However, the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 71
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology